A rare and fatal form of muscular dystrophy has long posed a devastating diagnosis for children, primarily affecting boys.

Drug developer PepGen said on Wednesday it will discontinue development of its experimental therapy for Duchenne muscular dystrophy (DMD) after it failed to boost production of a protein in a ...

Delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), showed high dystrophin expression and a ...

A Co Down woman is encouraging people living with a muscle wasting or weakening condition, their families and carers to join ...

I had the pleasure of attending a Netflix event around the WoW documentary The Remarkable Life of Ibelin last year—one that was attended by folks from Muscular Dystrophy UK, a charity that helps fund ...

Muscular dystrophy, known as DMD ... they adopted him despite signs of a muscular disorder — and never looked back. "We're not going to live the rest of our life in fear of what could happen ...

No clinically significant changes were observed on physical examination, in vital signs, or on electrocardiograms ... in patients with Duchenne's muscular dystrophy. No serious adverse events ...

Capricor Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) plans to convene a panel of outside experts before deciding on the company's cell therapy for a heart condition related ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and ...

Taevion Norris’ senior year was interrupted due to heart failure, but that did not stop him from graduating on time at Lurie ...

Duchenne muscular dystrophy (DMD), recognised by the World ... neurologist and epileptologist, Medical Trust Hospital, Kochi, early signs of DMD include delays in walking, toe walking, stiffness ...

DMD treatment SAT-3247 was safe and well-tolerated, and showed signs of increasing muscle strength in five adults, Satellos ...